Structure-activity relationship (SAR) is the relationship between a compound’s chemical structure and its biological activity. It involves modifying a molecule by adding or removing functional groups, or altering their positions, to develop compounds with enhanced pharmacological action, reduced side effects, and improved bioavailability.
Even a tiny modification can drastically affect the overall function and effects of a drug. This is why such changes must be handled with precision to ensure the safety and efficacy of drugs and patient outcomes.
For example, a slight modification in Morphine led to Codeine, which is less potent but has increased oral bioavailability and fewer severe adverse effects.
The case of Thalidomide highlights how small structural differences have a major impact on public health. Its enantiomers exhibited drastically different effects; the (S) enantiomer was teratogenic, causing birth defects, while the (R) enantiomer was a sedative. This explains the importance of SAR in drug discovery and safety.
In drug design, even the smallest structural change can be the difference between harm and healing.
Can you think of another drug where a small structural change made a big clinical difference?
MBH/PS